Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients—Potential Impact on PSMA-Guided Radiation Therapy

Sokoloff RL, Norton KC, Gasior CL et al (2000) A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine. Prostate 43:150–157

CAS  Article  Google Scholar 

Ross JS, Sheehan CE, Fisher HA et al (2003) Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 9:6357–6362

CAS  PubMed  Google Scholar 

Perner S, Hofer MD, Kim R et al (2007) Prostate-specific membrane antigen expression as a predictor of prostate cancer progression. Hum Pathol 38:696–701

CAS  Article  Google Scholar 

Bednarova S, Lindenberg ML, Vinsensia M et al (2017) Positron emission tomography (PET) in primary prostate cancer staging and risk assessment. Transl Androl Urol 6:413–423

Article  Google Scholar 

Eiber M, Fendler WP, Rowe SP et al (2017) Prostate-specific membrane antigen ligands for imaging and therapy. J Nucl Med 58:67S-76S

CAS  Article  Google Scholar 

Afshar-Oromieh A, da Cunha ML, Wagner J et al (2021) Performance of 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients. Eur J Nucl Med Mol Imaging 48:2925–2934

Article  Google Scholar 

Abghari-Gerst M, Armstrong WR, Nguyen K et al (2022) A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: results from a prospective multicenter study on 2,005 patients. J Nucl Med 63:567–572

Article  Google Scholar 

Afshar-Oromieh A, Malcher A, Eder M et al (2013) PET imaging with a 68Gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging 40:486–495

CAS  Article  Google Scholar 

Eder M, Neels O, Muller M et al (2014) Novel preclinical and radiopharmaceutical aspects of 68Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals (Basel) 7:779–796

CAS  Article  Google Scholar 

Giesel FL, Hadaschik B, Cardinale J et al (2017) F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging 44:678–688

CAS  Article  Google Scholar 

Giesel FL, Knorr K, Spohn F et al (2019) Detection efficacy of 18F-PSMA-1007 PET/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy. J Nucl Med 60:362–368

CAS  Article  Google Scholar 

Wondergem M, van der Zant FM, Knol RJJ et al (2017) 18F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes: detection rate, image quality, activity kinetics, and biodistribution. J Nucl Med 58:1797–1804

CAS  Article  Google Scholar 

Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 76:340–351

Article  Google Scholar 

D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974

Article  Google Scholar 

Arnfield EG, Thomas PA, Roberts MJ et al (2021) Clinical insignificance of [18F]PSA-1007 avid non-specific bone lesions: a retrospective evaluation. Eur J Nucl Med Mol Imaging 48:4495–4507

CAS  Article  Google Scholar 

Rahbar K, Afshar-Oromieh A, Seifert R et al (2018) Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging 45:2055–2061

CAS  Article  Google Scholar 

AhmadiBidakhvidi N, Laenen A, Jentjens S et al (2021) Parameters predicting 18F-PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer. EJNMMI Res 11:41

CAS  Article  Google Scholar 

Sachpekidis C, Baumer P, Kopka K et al (2018) 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging 45:904–912

CAS  Article  Google Scholar 

Afshar-Oromieh A, Vollnberg B, Alberts I et al (2019) Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis. Eur J Nucl Med Mol Imaging 46:2289–2297

Article  Google Scholar 

Zhou J, Gou Z, Wu R et al (2019) Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Skeletal Radiol 48:1915–1924

Article  Google Scholar 

Hernandez D, Salas D, Gimenez D et al (2015) Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy. Radiat Oncol 10:262

CAS  Article  Google Scholar 

Liauw SL, Pitroda SP, Eggener SE et al (2013) Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Int J Radiat Oncol Biol Phys 85:378–384

Article  Google Scholar 

Stoll M, Stoiber EM, Grimm S et al (2016) Comparison of safety margin generation concepts in image guided radiotherapy to account for daily head and neck pose variations. PLoS ONE 11:e0168916

Article  Google Scholar 

Peters N, Wohlfahrt P, Hofmann C et al (2022) Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction. Radiother Oncol 166:71–78

Article  Google Scholar 

Trofimov A, Nguyen PL, Coen JJ et al (2007) Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys 69:444–453

Article  Google Scholar 

Kerkmeijer LGW, Groen VH, Pos FJ et al (2021) Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the flame randomized phase iii trial. J Clin Oncol 39:787–796

CAS  Article  Google Scholar 

Salembier C, Villeirs G, De Bari B et al (2018) ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiother Oncol 127:49–61

Article  Google Scholar 

留言 (0)

沒有登入
gif